COZZI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.639
EU - Europa 1.126
AS - Asia 284
OC - Oceania 21
AF - Africa 12
Totale 4.082
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.636
RU - Federazione Russa 490
IE - Irlanda 154
SE - Svezia 122
IT - Italia 90
SG - Singapore 89
UA - Ucraina 82
HK - Hong Kong 60
DE - Germania 54
CN - Cina 52
FI - Finlandia 39
TR - Turchia 35
GB - Regno Unito 24
AU - Australia 21
CH - Svizzera 20
IN - India 18
PL - Polonia 18
VN - Vietnam 18
BE - Belgio 13
CI - Costa d'Avorio 8
JO - Giordania 8
FR - Francia 6
RO - Romania 6
BG - Bulgaria 5
SC - Seychelles 4
CA - Canada 3
NL - Olanda 2
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
LT - Lituania 1
TW - Taiwan 1
Totale 4.082
Salva come PNG Salva come JPEG
Città #
Santa Clara 672
Fairfield 291
Chandler 193
Ashburn 177
Dublin 154
Woodbridge 131
Cambridge 127
Jacksonville 123
Houston 119
Seattle 107
Wilmington 98
Ann Arbor 78
Singapore 69
Altamura 41
Princeton 39
Lawrence 36
Boardman 35
Boston 28
Hong Kong 28
Melbourne 21
Bern 20
Shanghai 20
San Diego 19
Beijing 18
Dong Ket 18
Warsaw 18
Mumbai 17
Washington 16
Medford 14
Brussels 13
Izmir 13
Buffalo 12
Los Angeles 11
Norwalk 10
Abidjan 8
Florence 8
New York 8
Milan 7
Timisoara 6
Auburn Hills 5
Sofia 5
Andover 4
Hillsboro 4
London 4
Moscow 4
Salerno 4
Verona 4
Yubileyny 4
Toronto 3
Capri 2
Falls Church 2
Frankfurt Am Main 2
Heidelberg 2
Helsinki 2
Kent 2
Tappahannock 2
Amsterdam 1
Arnsberg 1
Chicago 1
Frankfurt am Main 1
Hangzhou 1
Jakarta 1
Jerusalem 1
Lappeenranta 1
Laurel 1
Napoli 1
Philadelphia 1
Pune 1
Rome 1
Saint Petersburg 1
San Mateo 1
Taichung 1
Thiene 1
Tokyo 1
Totale 2.896
Salva come PNG Salva come JPEG
Nome #
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. 173
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 146
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 143
NAPOR-3 RNA binding protein is required for apoptosis in hippocampus 137
Acute phencyclidine administration reduces extracellular glutamate levels and the expression of synaptophysin and SNAP-25 in rat frontal cortex 122
Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro. 121
Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. 121
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 120
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 119
Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice. 119
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. 118
Poly (ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia 118
Transient focal ischemia triggers neuronal expression of GAT-3 in the rat perilesional cortex 118
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo. 116
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors 116
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 114
1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia 114
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. 114
The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine 113
Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors 110
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 110
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus 109
GAT-1 regulates both tonic and phasic GABAA receptor-mediated inhibition in the cerebral cortex 109
Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage 109
GPR35 is functionally expressed in astrocytes and mediates kynurenic acid-dependent reduction of excitatory synaptic activity at CA3-CA1 synapse. 102
Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity? 101
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death 101
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 100
Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. 97
Alteration of the subcellular and tissue distribution of ELAV-type proteins during cerebral ischemia in the rat 95
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 82
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 81
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia 80
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 78
GLT-1 expression and glutamate uptake in rat cerebral cortex are increased by phencyclidine 77
Protection with mGlu1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms 74
Kynurenic acid actions in brain and periphey 69
The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil. 57
Totale 4.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020325 0 0 0 0 0 0 73 86 67 37 50 12
2020/2021352 37 21 25 47 7 33 9 32 29 44 23 45
2021/2022244 10 25 15 11 11 11 15 16 14 11 38 67
2022/2023740 65 120 42 57 67 133 101 39 65 5 17 29
2023/2024237 7 26 47 22 23 53 11 33 3 3 4 5
2024/20251.423 56 174 110 280 613 189 1 0 0 0 0 0
Totale 4.103